Health Care: Drugs

Immunomedics Inc (IMMU: NASDAQ)

$7.47 -0.03 | -0.4%
05/25/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 7.50
52 Week High 7.70
52 Week Low 1.95
Avg. Daily Vol. (Mil) 3.38
Beta (3 year) 3.00
Share Related Items
Mkt Cap (Mil) 822.03
Shares Out (Mil) 109.60
Float (Mil) 99.55
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.60
Current Ratio 0.60
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 243.09
Price/Book 0.00
Price/Cash Flow -7.20
Per Share Data
Earnings -1.11
Sales 0.03
Book Value 0.00
Cash Flow -1.04
Business Summary
Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
General Information
300 The American Road
Morris Plains, NJ 07950
www.immunomedics.com
Industry : Drugs
Sector: Health Care
Employees: 131
CEO: Michael Garone
Short Interest
Current Month (Mil) 28.63
Previous Month (Mil) 25.46
Short Interest Ratio (Days) 13.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -220.00
Return on Investments 348.50
Profitability
Gross Margin 66.40
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with IMMU

Latest IMMU Headlines from TheStreet

More Financial News for IMMU

Press Releases for IMMU

See All Press Releases

Partner Headlines for IMMU

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter